• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Biomol Struct Dyn . Promising Inhibitors of Main Protease of Novel Corona Virus to Prevent the Spread of COVID-19 Using Docking and Molecular Dyn

tetano

Editor, Senior Moderator
J Biomol Struct Dyn


. 2020 Jun 22;1-15.
doi: 10.1080/07391102.2020.1779131. Online ahead of print.
Promising Inhibitors of Main Protease of Novel Corona Virus to Prevent the Spread of COVID-19 Using Docking and Molecular Dynamics Simulation


Durgesh Kumar[SUP] 1 2 [/SUP], Kamlesh Kumari[SUP] 3 [/SUP], Vijay Kumar Vishvakarma[SUP] 1 2 [/SUP], Abhilash Jayaraj[SUP] 4 [/SUP], Dhiraj Kumar[SUP] 5 [/SUP], Venkatesh Kumar Ramappa[SUP] 6 [/SUP], Rajan Patel[SUP] 7 [/SUP], Vinod Kumar[SUP] 8 [/SUP], Sujata K Dass[SUP] 9 [/SUP], Ramesh Chandra[SUP] 2 [/SUP], Prashant Singh[SUP] 9 [/SUP]



Affiliations

Abstract

Coronavirus disease-2019 (COVID-19) is a global health emergency and the matter of serious concern, which has been declared a pandemic by WHO. Till date, no potential medicine/ drug is available to cure the infected persons from SARS-CoV-2. This deadly virus is named as novel 2019-nCoV coronavirus and caused coronavirus disease, that is, COVID-19. The first case of SARS-CoV-2 infection in human was confirmed in the Wuhan city of the China. COVID-19 is an infectious disease and spread from man to man as well as surface to man . In the present work, in silico approach was followed to find potential molecule to control this infection. Authors have screened more than one million molecules available in the ZINC database and taken the best two compounds based on binding energy score. These lead molecules were further studied through docking against the main protease of SARS-CoV-2. Then, molecular dynamics simulations of the main protease with and without screened compounds were performed at room temperature to determine the thermodynamic parameters to understand the inhibition. Further, molecular dynamics simulations at different temperatures were performed to understand the efficiency of the inhibition of the main protease in the presence of the screened compounds. Change in energy for the formation of the complexes between the main protease of novel coronavirus and ZINC20601870 as well ZINC00793735 at room temperature was determined on applying MM-GBSA calculations. Docking and molecular dynamics simulations showed their antiviral potential and may inhibit viral replication experimentally. Communicated by Ramaswamy H. Sarma.

Keywords: MD simulations; MM-GBSA; SARS-CoV-2; ZINC database; docking; inhibitors.
 
Back
Top Bottom